Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Self-citationDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 3
- CELL 78: 23 (1994).
- Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
- Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).
Cited by
Items 701–800 of 885
Murine Models of Huntington Disease
Sturrock, A., & Leavitt, B. R. (2009) · Future Neurology · doi:10.2217/fnl.09.34
Ribeiro, M. J. R. F. (2010) · Repository of UTAD (Universidad De Tras-os Montes e Alto Douro)
Cellular Mechanisms of Brain Damage
Savettieri, G., Liegro, I. D., & Cestelli, A. (2000) · Springer eBooks · doi:10.1007/978-88-470-2286-7_40
Huntington's Disease: Function and Dysfunction of Huntingtin in Axonal Transport
Saudou, F., & Humbert, S. (2009) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-87941-1_9
Análise molecular da Ataxina 1
Santos, K. P. M. (2012) · doi:10.47749/t/unicamp.2012.849855
Rupp, J. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1944
Structural study of polyglutamine and molecular mechanism of toll-like receptor signaling
Liu, Z. (2009) · OakTrust (Texas A&M University Libraries)
Mutant huntingtin enhanced sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity
Zeron, M. M. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0090647
Wild-type huntingtin function in BDNF transcription and in neural differentiation
Ramos, C. (2007) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/yheq-1c71
Yerkes, S. (2009) · Library, Museums and Press - UDSpace (University of Delaware)
BNIP3: A POTENTIAL TARGET FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION IN HUNTINGTON'S DISEASE.
Colciago, C. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/colciago-clarissa_phd2012-01-23
Thiele, J. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0069669
Hosier, G. W. (2012) · DalSpace (Dalhousie University)
The role of palmitoylation in the pathogenesis of Huntington disease
Sanders, S. S. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0167072
IL RUOLO DELL�HUNTINGTINA NELLA FISIOLOGIA DEL DIFFERENZIAMENTO NEURONALE E NELLA PATOLOGIA
Camnasio, S. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/camnasio-stefano_phd2014-01-16
Graham, R. K. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0092837
Eine epidemiologische Studie im süddeutschen Raum
Rehm, M. M. (2004)
MALATTIA DI HUNTINGTON AD ESORDIO TARDIVO:ENTITA� CLINICA DISTINTA?
Capiluppi, E. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/capiluppi-elisa_phd2015-11-19
Biology and characterisation of polyalanine as an emerging pathological marker
Stochmanski, S. J. (2014) · doi:10.71781/32370
Huang, B. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1126
Spinocerebellar ataxia : a clinical and molecular genetic study.
Worth, P. F. (2002) · OpenGrey (Institut de l'Information Scientifique et Technique)
Calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease
Simões, A. T. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Behavioral Characterization of a Knock-in Mouse Model of Huntington's Disease
Minnig, S. (2016) · Western CEDAR (Western Washington University) · doi:10.25710/f5yg-9v24
Huntington’s Disease: Mechanisms Of Pathogenesis And Development Of New Therapies
Raymond, L. A., & Leavitt, B. R. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch16
Model Organisms and Neurogenetics
Krantz, D. E., & Jackson, G. R. (2007) · Medical psychiatry · doi:10.3109/9781420019544.006
Scoberg-Evans, J. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Kwakye, G. F., & Bowman, A. B. (2009)
Excitotoxicity and bioenergetics in Huntington's disease transgenic neurons
Carrier, R. L. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
A study of depression in Huntington's disease
Pang, T. Y. (2008) · Minerva Access (University of Melbourne)
The role of the Raf family in development
Luckett, J. (2000) · Figshare
Mechanisms of neurodegeneration in transgenic models of Huntington's disease
Gil, J. M. D. A. C. (2007) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The role of caspase-2 in the progression of Huntington disease in the YAC128 mouse
Carroll, J. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0343315
Turner, L. (2016) · ANU Open Research (Australian National University) · doi:10.25911/5d7636f5dc384
MALATTIA DI HUNTINGTON AD ESORDIO TARDIVO: ENTITA' CLINICA DISTINTA?
Mariani, C. B., Della, D., & Weinstein, R. (2015)
(2010) · Pergamon materials series · doi:10.1016/s1470-1804(09)01516-8
Romo, L. (2017) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2ft26
Eisenablagerungen in den Basalganglien bei Morbus Huntington
Leske, D. (2007) · mediaTUM (Technical University of Munich)
Huntingtin function during zebrafish (Danio rerio) development.
Henshall, T. L. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Valdeolivas, S. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
da Fonsêca, V. S. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Laroche, M. (2017) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Rôle de la huntingtine dans le muscle
Poreau, B. (2017) · theses.fr (ABES) · doi:10.70675/31b5a39fz3cddz4274zaa72ze88e38887ab7
Mechanisms of inclusion assembly in Huntington’s disease
Trubetskov, M. M. (2017) · Minerva Access (University of Melbourne)
Understanding Huntington's disease using Machine Learning Approaches
Lokhande, S. (2017) · Scholarship - Claremont (Claremont Colleges) · doi:10.5642/kgitd/4
Finding balance in Huntington's disease: PIAS1 and huntingtin in protein homeostasis
Ochaba, J. (2016) · eScholarship (California Digital Library)
Caballol, N. S. (2018) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Structures of Triplet Repeat Dnas Associated with Human Diseases
Yu, A. (1996) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University)
Hu, Q. (2016) · TSpace (University of Toronto)
Lu, B., & Fu, Y. (2016) · Scientia Sinica Vitae · doi:10.1360/n052016-00106
Cardiac Effects of Huntington’s Disease in Murine Models
Child, D. D. (2019) · ScholarlyCommons (University of Pennsylvania)
Alterations of neuronal activity and protein homeostasis in a mouse model of Huntington’s disease
Schulz‐Trieglaff, E. K. (2018) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.22043
Identification of cellular signaling events dysregulated in Huntington’s disease.
Baharani, A. (2019) · HARVEST (University of Saskatchewan)
Energy metabolism as a target for new treatment strategies in Huntington’s disease
Sjögren, M. (2019) · Lund University Publications (Lund University)
IP3 Receptor and Ca2+ Signaling
Hisatsune, C., & Mikoshiba, K. (2009) · Springer eBooks · doi:10.1007/978-0-387-30370-3_31
Huntingtine et développement cortical
Friec, J. L. (2019) · theses.fr (ABES) · doi:10.70675/4943873azb2c6z432czb281z1dea6b17d318
Fast Voltage-Gated Sodium Channel Currents and Action Potential Firing in R6/2 Skeletal Muscle
Reed, E. J. (2018) · OhioLink ETD Center (Ohio Library and Information Network)
Polyglutamine (PolyQ) Diseases: Molecular pathology to treatment
Fawzy, A. (2015) · Biochemistry Letters · doi:10.21608/blj.2015.63845
Nucleic acid structures as transcriptional and epigenetic regulators in health and disease
Cravo, L. M. L. D. S. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-e9bq5wwe6
Axon pathology in mouse models of Huntington's disease
Marangoni, M. (2014) · Nottingham ePrints (University of Nottingham)
Microglial Mitophagy and Neurodegenerative Disorders
Oyindamola, E. A., Agyemang, M. K., Owusu-Sarfo, J., Yeboah, K. O., & Osafo, N. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch004
Zhang, R. (2018) · eScholarship (California Digital Library)
Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2
Mitochondrial characterization in Huntington's Disease fibroblasts and iPSC-derived cells
Beatriz, M. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Mena, D. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
CRISPR/Cas9 pour traiter la maladie de Huntington
Dufour, J. (2020) · Corpus Université Laval (Université Laval)
The Mutant HTT mRNA-Protein Interactome
Schilling, J. (2017) · DZNE Pub
Genetic and Molecular analysis of the Spinocerebellar ataxia type 7 (SCA7) disease gene
Jonasson, J. (2000) · DiVA at Umeå University (Umeå University)
Somatic Gene Transfer and Cell Transplantation Strategies for Neurodegenerative Diseases
Thode, S., Raymon, H. K., & Gage, F. H. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-476-4_15
Domain Organization of Mutant Huntingtin Fibrils
Bugg, C. W. (2011) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/xayy-9e20
Mak, T. W., Penninger, J. M., Roder, J., Rossant, J., & Saunders, M. E. (1998) · Elsevier eBooks · doi:10.1016/b978-012466044-1/50245-3
Wahłsten, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812832-9.00009-9
Faculty Opinions recommendation of SRCP1 conveys resistance to polyglutamine aggregation.
Gomer, R. H. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733671907.793549116
MacDonald, M. E. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_97
Self-citationDisney, M. D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736176320.793563807
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_140-1
RNA-mediated pathogenic mechanisms in Huntington's disease
Bates, G. P., Fieńko, S., Landles, C., & Papadopoulou, A. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00005-4
Huntingtin regulates cytoskeleton organisation during axonal growth
Carpentier, R. (2022) · theses.fr (ABES) · doi:10.70675/a8fdd4e1z6f9az42e3zb2e4z9ebead2e65f4
Rôle de la Huntingtine dans la maturation des neurones corticaux
Wennagel, D. (2022) · theses.fr (ABES) · doi:10.70675/337d4e5az9371z41adzb869z7a4c260047e4
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357707
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357692
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357695
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357728
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357713
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357710
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357704
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357719
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357701
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357716
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357725
Seefelder, M., Alva, V., Huang, B., Engler, T., Baumeister, W. P., Guo, Q., Fernández‐Busnadiego, R., Lupas, A. N., & Kochanek, S. (2020) · Figshare · doi:10.6084/m9.figshare.13357722
Rôles normal et pathologique des phosphorylations de la huntingtine par Cdk5
M’Barek, K. B. (2012) · theses.fr (ABES) · doi:10.70675/53a5c6a1zd813z445bza73bza84d5d3008fa
Metadata
- Authors
- Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- MacDonald, Marcy E.
- Venue
- Science
- Published
- 1995-07-21
- Volume
- 269
- Issue
- 5222
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002644780
- Cited by
- 723
- References
- 29
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 21 · 2014: 33 · 2013: 22 · 2012: 32
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 16367, NS32765, R01NS032765)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Huntington's disease, huntingtin, gene targeting, embryonic lethality, gastrulation, loss of function, gain-of-function, CAG repeat expansion, mouse model, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Base Sequence, Cell Line, Ectoderm, Female, Embryonic and Fetal Development, Genotype, Heterozygote, Homozygote, Humans, Huntington Disease, Male, Mesoderm, Mice, Inbred C57BL, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Phenotype, Stem Cells, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.